Merck (MRK) EBT (2009 - 2026)

Merck has disclosed EBT across 18 years of filings, most recently posting -$3.5 billion for Q1 2026.

• In Q1 2026, EBT fell 159.29% year-over-year to -$3.5 billion; the TTM figure through Mar 2026 stood at $11.7 billion (down 42.17% YoY), while the FY2025 annual figure was $21.1 billion, up 5.67% from the prior year.
• EBT retreated to -$3.5 billion in Q1 2026, from $3.4 billion in the prior quarter.
• Over the last five years, EBT for MRK reached as high as $6.7 billion in Q3 2025 and fell as low as -$5.3 billion in Q2 2023.
• The 5-year median for EBT is $4.2 billion (2024), against an average of $3.3 billion.
• Annual changes were most pronounced in 2023 — EBT tumbled 218.12% — and 2024, when it jumped 303.81%.
• A 5-year view of EBT shows it stood at $3.5 billion in 2022, then slumped by 158.24% to -$2.0 billion in 2023, then jumped by 303.81% to $4.2 billion in 2024, then fell by 17.99% to $3.4 billion in 2025, then plunged by 202.34% to -$3.5 billion in 2026.
• According to Business Quant data, EBT over the past three periods registered -$3.5 billion, $3.4 billion, and $6.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.